Radioligand binding studies identify 5-HT3 recognition sites in neuroblastoma cell lines and mammalian CNS
- 31 July 1988
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 9 (7) , 227-229
- https://doi.org/10.1016/0165-6147(88)90145-9
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- [3H]Quaternised ICS 205-930 labels 5-HT3 receptor binding sites in rat brainEuropean Journal of Pharmacology, 1988
- The potential anxiolytic activity of GR38032F, a 5‐HT3‐receptor antagonistBritish Journal of Pharmacology, 1988
- [3H]Quipazine labels 5-HT3 recognition sites in rat cortical membranesEuropean Journal of Pharmacology, 1988
- Effects of the 5‐HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brainBritish Journal of Pharmacology, 1987
- Identification and distribution of 5-HT3 receptors in rat brain using radioligand bindingNature, 1987
- Pharmacological characterization of 5‐hydroxytryptamine‐induced depolarization of the rat isolated vagus nerveBritish Journal of Pharmacology, 1987
- Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugsNature, 1985
- Study of the contractile effect of 5-hydroxytryptamine (5-HT) in the isolated longitudinal muscle strip from guinea-pig ileumNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1985
- Blockade of serotonin receptors on autonomic neurones by (−)-cocaine and some related compoundsEuropean Journal of Pharmacology, 1979
- TWO KINDS OF TRYPTAMINE RECEPTORBritish Journal of Pharmacology and Chemotherapy, 1957